Search clinical trials for: Solid tumors with NTRK or ROS1 gene fusion
Total 394205 results
-
University College, LondonCompletedGallbladder Cancer | Extrahepatic Bile Duct CancerUnited Kingdom
-
Hoffmann-La RocheActive, not recruitingMelanoma | Renal Cell Carcinoma | Adult Solid Tumor | Breast Cancer | Head and Neck Neoplasms | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Neuroendocrine Tumors | Lymphoma, Large-Cell, Anaplastic | Cholangiocarcinoma | Papillary Thyroid Cancer | Sarcomas | Salivary Gland Cancers and other conditionsUnited States, China, Korea, Republic of, Australia, Taiwan, France, Spain, United Kingdom, Hong Kong, Belgium, Italy, Germany, Japan, Singapore, Netherlands, Poland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene FusionChina
-
Queen Elizabeth II Health Sciences CentreNova Scotia Health Research FoundationCompletedCoronary Artery Disease | Type 2 Diabetes Mellitus | Angina Pectoris | Percutaneous Coronary InterventionCanada
-
TakedaCompletedCarcinoma, Advanced ALK+ or ROS1+Non-Small-Cell Lung, Neoplasm, Advanced ALK+ or ROS1+Solid TumorsSpain, Italy, Netherlands, France
-
Turning Point Therapeutics, Inc.Zai Lab (Shanghai) Co., Ltd.RecruitingLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, China, Japan, Australia, Belgium, Canada, Denmark, France, Germany, Hong Kong, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Netherlands, Poland, Singapore, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheActive, not recruitingSolid Tumors | CNS TumorsUnited States, Spain, Korea, Republic of, Canada, Germany, United Kingdom, China, Italy, Hong Kong, France, Taiwan
-
Hoffmann-La RocheNo longer availableCancers With NTRK, ROS1, or ALK Gene FusionsUnited States
-
AdventHealth Translational Research InstituteCompletedObesity | HyperglucagonemiaUnited States
-
Guangzhou JOYO Pharma Co., LtdRecruitingLung Neoplasms | Brain Neoplasms | Protein Kinase Inhibitors | Other Protocol Specified CriteriaChina
-
University of UtahAbbottCompletedRetinopathy of PrematurityUnited States
-
Centre Leon BerardHoffmann-La RocheActive, not recruitingSoft Tissue Sarcoma | Metastatic Cancer | Advanced CancerFrance
-
Daiichi Sankyo Co., Ltd.CompletedAdvanced Solid Malignant TumorsJapan
-
Sameek RoychowdhuryNational Cancer Institute (NCI)WithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ALK Gene Mutation | Metastatic Malignant Neoplasm in the Brain | Advanced Malignant Neoplasm | ALK Fusion Protein Expression | Metastatic Malignant Neoplasm in the Central Nervous System | ROS1 Gene Mutation | ALK Gene... and other conditionsUnited States
-
Addario Lung Cancer Medical InstituteCompletedALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive TumorsROS1-fusion Positive TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Maastricht UniversityCompleted
-
Puerta de Hierro University HospitalCompletedPostmenopausal DisorderSpain
-
Turning Point Therapeutics, Inc.RecruitingLymphoma | Locally Advanced Solid Tumors | Metastatic Solid Tumors | Primary CNS TumorsUnited States, Korea, Republic of, Spain, Singapore, Taiwan, Australia, Italy, Canada, France, Denmark, United Kingdom
-
Novartis PharmaceuticalsTerminatedCeritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (SIGNATURE)Tumors With Aberrations in ALK or ROS1United States
-
PfizerActive, not recruiting
-
USDA Grand Forks Human Nutrition Research CenterCompletedResonance Raman Spectroscopy for Dietary Carotenoid IntakeUnited States
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
PfizerCompleted
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNon-small Cell Lung Cancer Metastatic | Targetable Oncogenes (EGFR, ALK, ROS1)United States
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.RecruitingCarcinoma, Non-Small-Cell LungJapan, China, Canada, Spain, Germany, Korea, Republic of, Austria, Brazil, Greece, France, United States, Italy, Argentina, Chile, Hungary, India, Turkey, Romania, Switzerland, Netherlands, Poland
-
PfizerOxOnc Development LPCompletedNon Small Cell Lung Cancer | Crizotinib | ROS1 Proto OncogeneKorea, Republic of, China, Taiwan, Japan
-
Shanghai Fosun Pharmaceutical Industrial Development...RecruitingAdvanced Solid Tumor | Advanced Cancer | Lung Cancer, Nonsmall CellChina
-
Hoffmann-La RocheRecruitingCarcinoma, Non-Small-Cell LungBrazil, China, France, Croatia, Greece, Italy, Mexico, Spain, India, Netherlands, Romania, Sweden, Thailand, Lebanon, Turkey, Slovakia, Jordan, Russian Federation, Germany
-
MedSIRMedical University of ViennaNot yet recruitingNSCLC | Brain Metastases | ROS1 Gene Rearrangement
-
Betta Pharmaceuticals Co., Ltd.UnknownLung Cancer | ROS1 Gene RearrangementChina
-
University of Colorado, DenverJanssen Research & Development, LLCRecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
PfizerNo longer available
-
PfizerRecruitingNSCLC | IMT | ALCLChina, Taiwan, Japan, Russian Federation, Italy
-
GlaxoSmithKlineWithdrawn
-
Xuanzhu Biopharmaceutical Co., Ltd.RecruitingLocally Advanced or Metastatic Solid Tumors | Locally Advanced or Metastatic Non-small Cell Lung CancerChina
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Not yet recruitingNon-Small Cell Lung CancerUnited States
-
University of ColognePfizer; Spanish Lung Cancer GroupCompletedAdenocarcinoma | NSCLC | Lung CancerGermany, Spain, Switzerland
-
PfizerNo longer availableNeoplasms | Carcinoma, Non-Small-Cell LungJapan
-
Fondazione Ricerca TraslazionaleUnknownCarcinoma, Non-Small-Cell LungItaly
-
PfizerFrench College of General Hospital Pneumologists (CPHG)CompletedNSCLC | Crizotinib | ALK Gene Rearrangement or ROS1 Gene RearrangementFrance
-
Yonsei UniversityUnknownNon-small Cell Lung Cancer Harboring ROS1 RearrangementKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | ROS1 Gene Rearrangement | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | ALK PositiveUnited States
-
TYK Medicines, IncRecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingNon Small Cell Lung Cancer MetastaticFrance
-
Centre Hospitalier Intercommunal CreteilCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eli Lilly and Company; Genentech, Inc.; Kazia... and other collaboratorsRecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Brain | NTRK Family Gene Mutation | CDK Gene Mutation | PI3K Gene Mutation | ROS1 Gene Mutation | KRAS G12C MutationUnited States
-
Fondazione Ricerca TraslazionaleClinical research technology SrlActive, not recruitingCarcinoma, Non-Small-Cell LungItaly
-
Unilever R&DSt. John's Research InstituteCompletedAnxiety | Pharmacokinetics | CognitionIndia
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany